NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry

NCT05375942

CompletedN/A

Sponsor: Pfizer

Conditions: Arthritis, Rheumatoid

Interventions: Inflectra, Inflectra

Countries: United States

This is a retrospective observational study looking at the characteristics and outcomes of participants taking Inflectra using the CorEvitas Rheumatoid Arthritis Registry.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Be at least 18 years of age
* Have been diagnosed with RA by a rheumatologist
* Have initiated treatment with Inflectra
* Had assessment of effectiveness in patients who have at least one follow up visit.

Exclusion Criteria:

* No additional exclusion criteria

Locations (1)

Collegeville, Pennsylvania, United States